Vanderbilt study reveals mechanism for immunotherapy-related myocarditis

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from Vanderbilt-Ingram Cancer Center discovered that T-cells recognizing the cardiac antigen α-myosin are the mechanism for immunotherapy-related myocarditis. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login